PRESS RELEASE DUBLINandLOUISVILLE, Ky .,Oct. 2, 2015/PRNewswire/ –Allergan plc, a leading global specialty pharmaceutical organization, today announced a multi-year study collaboration withHumana Inc., one of the nation's leading health insurance and well-being companies, to explore new concepts and ways to improve the health and well-being of patients, associates and their caregivers. A primary objective of theAllerganandHumanacollaboration is definitely to review key issues and acquire a more comprehensive knowledge of opportunities for improvement in treatment delivery.

Allergan receives FDA approval to advertise 28 additional varieties of Natrelle 410 silicone-filled breasts implants Allergan, plc. today announced that the company has received acceptance from the U.S. The excess projection styles present surgeons more choices to better meet up with the individual needs of each patient. The complete 12 design matrix includes three heights and four projection designs, including a 7.S., providing surgeons and patients even more options to achieve preferred outcomes. In October 2015 These additional implant designs will be available to surgeons and individuals.